Mr Moch is the founder and president of Euclidean Life Science Advisors, which provides strategic advisory services to life sciences companies. He is a former managing director of ThinkEquity Partners, an investment bank focusing on high-growth companies, and former chairman, president and CEO of Alteon, a biotech company specializing in small molecule therapeutics for cardiovascular aging and diabetic complications.
Mr Moch holds a degree in biochemistry from Princeton University and received his MBA from the Stanford Graduate School of Business.
Michael Novinski, president and CEO of Emisphere, said: “Ken Moch has an impressive record advising the management and governing boards of biotechnology companies. His past experiences will provide leadership and benefit to Emisphere.”